Skip to main content

$0.056 -0.002 (-3.45%)

High

$0.06

Low

$0.06

Trades

69

Turnover

$115,211

Volume

1,984,515
30 June 2023 at 3:59pm
Register to track PYC and receive email alerts.
Subject
PYC Ann: Application for quotation of securities - PYC

PYC Ann: New U.S. Headquarters, and Residency at JLABS

PYC Ann: Second Drug Program Progressing Towards Human Trials

PYC Ann: Trading Halt

PYC Ann: Evercore ISI GenomeRx Emerging Therapeutic Company Day

PYC Ann: SECOND DRUG PROGRAM - EFFICACY DATA IN PATIENT CELL MODELS

PYC Ann: PYC Invited to Present at ARVO 2021 Annual Meeting

PYC Ann: Set To Announce Efficacy Results For Second Drug Program

PYC Ann: March 2021 Quarterly Report and Cashflow

PYC Ann: Corporate Presentation April 2021

PYC Ann: April Investor Call Presentation

PYC Ann: Preclinical Data - Superior PPMO Delivery to the Brain

PYC Ann: Quarterly Investor Call - 15th April 2021

PYC Ann: Appendix 3X - Initial Director's Interest Notice

PYC Ann: Appendix 3G - Issue of Options

PYC Ann: PYC Appoints U.S. Biopharma Exec Jason Haddock to its Board

PYC Ann: Director Retirement

PYC Ann: Appendix 3G - Issue of Options

PYC Ann: Initial Director's Interest Notice

PYC Ann: Participation in SVB Leerink Biopharma Private Co Connect

PYC Ann: PYC Appoints US Biotech Veteran to its Board of Directors

PYC Ann: Lead Investigational Drug Demonstrates Key Improvement

PYC Ann: Half Year Accounts and Appendix 4D

PYC Ann: PYC Expands US Executive Leadership Team

PYC Ann: Progress US Clinical Stage Company and Corporate Objectives

PYC Ann: Change of Director's Interest Notice

PYC Ann: PYC to Participate in RNA Discussion - CEO BIO Conference

PYC Ann: Quarterly Activities Report and Appendix 4C

PYC Ann: ICR Conference Presentation

PYC Ann: PYC to Present at ICR Westwicke Conference

PYC Ann: Appendix 3G

PYC Ann: Initial Director's Interest Notice

PYC Ann: Visual Evidence of Lead Drugs Efficacy

PYC Ann: Letter to Shareholders from the US CEO

PYC Ann: Appointment of Chief Executive Officer in the United States

PYC Ann: PYC to Present at the Evercore ISI Conference

PYC Ann: Change in substantial holding

PYC Ann: Retail Entitlement Offer Share Issue and Appendix 2A

PYC Ann: Completion of Retail Entitlement Offer

PYC Ann: Final Director's Interest Notice

PYC Ann: New Constitution

PYC Ann: Results of Annual General Meeting

PYC Ann: AGM Chairman's Address and CEO Presentation

PYC Ann: Grants Awarded to Support Clinical Progression of Lead Drug

PYC Ann: Notice under Section 708(A)

PYC Ann: Change of Director's Interest Notice x 2

PYC Ann: Change in substantial holding

PYC Ann: Appendix 2A

PYC Ann: Review of Activities and Appendix 4C

PYC Ann: Dispatch of Notice to Ineligible Retail Shareholders

Register to track PYC and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
RAC
TLX